The purpose of this project is to establish a phage-based biomarker screening assay to recognize AD in human blood and cerebrospinal samples. Specifically, I will be completing ELISA screening of available phage that were identified in prior semesters to identify candidate phage for for further testing.
Phase 1 is to identify phages that recognize PTM changes in tau, and phase 2 is to test the phage in a large array of clinical samples of human blood and cerebrospinal fluid.
Files and links (1)
pdf
Analyzing CSF tau concentrations in Alzheimer's disease and control patients3.23 MBDownloadView
Presentationpdf Open Access
Related links
Details
Title
Analyzing CSF tau concentrations in Alzheimer's disease and control patients
Resource Type
Poster
Event
Summer Undergraduate Research Program (University of West Florida, Pensacola, Florida, 2021)
Contributors
Dr. Rodney P. Guttmann (Faculty Mentor)
Publisher
University of West Florida Libraries; Argo Scholar Commons
Format
pdf
Copyright
Permission granted to the University of West Florida Libraries to digitize and/or display this item for non-profit research and educational purposes. Any reuse of this item in excess of fair use or other copyright exemptions requires the permission of the copyright holder.
Identifiers
99380090298106600
Academic Unit
Biology; Summer Undergraduate Research Program 2021; Hal Marcus College of Science and Engineering
Language
English
Analyzing CSF tau concentrations in Alzheimer's disease and control patients